1. Startseite
  2. Aktien
  3. Schweiz
  4. Swiss Exchange
  5. BB Biotech AG
  6. News
  7. Andere Sprachen
    BION   CH0038389992

BB BIOTECH AG

(A0NFN3)
  Bericht
Verzögert Swiss Exchange  -  17:30 01.07.2022
57.10 CHF   +0.88%
24.05.BB BIOTECH AG : Disruptive Technologien verändern einen ganzen Sektor
EQ
24.05.BB BIOTECH AG : Disruptive Technologien verändern einen ganzen Sektor
DP
22.04.BB Biotech AG berichtet über die Ergebnisse für das erste Quartal zum 31. März 2022
CI
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über BB BIOTECH AG
24.05.BB BIOTECH AG : Disruptive technologies are changing an entire industry
19.05.BIOTECH : Keller (Bb Biotech), continua a crescere nonostante incertezza
22.04.BB Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2022
22.04.BB Biotech Swings To Q1 Loss As Total Returns Plummet
22.04.BB Biotech plombé au 1er trimestre par des marchés capricieux
22.04.BB BIOTECH : Rapporto intermedio al 31 marzo 2022
22.04.BB BIOTECH : Relazione finaziaria
22.04.BB Biotech AG pubblica il proprio rapporto intermedio
22.04.BB Biotech AG publishes its interim report
22.04.BB BIOTECH AG : Increased investment level balanced by established core holdings
22.04.BB BIOTECH AG : Posizioni principali affermate consentono un maggiore grado d'investimento
21.04.L'agenda di domani
21.04.L'agenda della settimana
20.04.BOLSA DE MADRID : El Nasdaq rebota, Netflix se hunde
20.04.Le Nasdaq se rebiffe, Netflix coule
20.04.AVIS D'ANALYSTES DU JOUR : Thales, Dassault Aviation, Leonardo, Ericsson, Virbac, Givaudan..
19.04.BB BIOTECH : Keller, grandi opportunita' per settore biotech
19.04.L'agenda della settimana
14.04.L'agenda della prossima settimana
12.04.GLOBAL MARKETS LIVE : Honda, Shopify, Meta, ASOS, Gilead Sciences...
12.04.BOURSE ZURICH : le SMI ancré dans le rouge en attendant l'inflation US
12.04.BB Biotech Launches New Share Repurchase Program
12.04.BOLA DE MADRID : El pueblo galo resiste
12.04.Le village gaulois
12.04.BOURSE ZURICH : repli attendu sur fond d'escalade des taux US
12.04.EN DIRECT DES MARCHES : AXA, EssilorLuxottica, TotalEnergies, bioMérieux, Givaudan, Sika, ..
12.04.BB Biotech boucle son programme de rachat d'actions et en lance un nouveau
12.04.BB Biotech AG concludes its share buyback program and launches a new buyback program
12.04.BB Biotech AG announces an Equity Buyback.
12.04.Tranche Update on BB Biotech AG’s Equity Buyback Plan announced on April 11, 2019.
12.04.BB Biotech AG authorizes a Buyback Plan.
11.04.BB Biotech AG's Equity Buyback announced on April 12, 2019, has expired with 0 shares, ..
30.03.IREN : Standard Ethics conferma il rating
22.03.BORSA I. : riprende in presenza la Star Conference 2022
21.03.Principales informations avant-Bourse
18.03.Principales informations avant-Bourse
17.03.In occasione dell'Assemblea generale annuale di BB Biotech AG gli azionisti hanno votat..
17.03.Shareholders at BB Biotech AG's AGM vote in favor of all proposals, approve the dividen..
17.03.Bb Biotech Ag Approves Dividend , Payable on March 23,2022
17.03.BB Biotech AG Announces Board Elections
19.02.Tranche Update on BB Biotech AG’s Equity Buyback Plan announced on April 11, 2019.
19.02.BB Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2021
18.02.BB Biotech; in 2021 perdita netta di 405 mln chf, dividendo a 3,85 chf/azione
18.02.BB BIOTECH : conferma dividendo ordinario a 3,85 chf/azione
18.02.BB BIOTECH : Esg
18.02.BB BIOTECH : in 2021 perdita netta di 405 mln chf (utile di 691 mln chf in 2020)
18.02.Principales informations avant-Bourse
18.02.BB Biotech AG publishes its 2021 annual report
18.02.L'agenda di oggi
18.02.BB Biotech Swings To FY21 Loss On Higher Operating Expenses
18.02.BB biotech confirme sa perte subie en 2021, mais aussi le dividende
18.02.BB BIOTECH : Business report
18.02.BB BIOTECH : Corporate Governance
18.02.BB BIOTECH : Remuneration Report
18.02.BB BIOTECH : Relazione della società
18.02.BB BIOTECH : Relazione sulle retribuzioni
18.02.BB Biotech AG publishes its 2021 annual report
18.02.BB Biotech AG pubblica il rapporto annuale 2021
16.02.L'agenda della settimana
14.02.L'agenda della settimana
11.02.L'agenda della prossima settimana
01.02.Xlife Sciences cotée sur SIX à partir du 11 février prochain
21.01.BB BIOTECH : chiude 2021 con una perdita di 405 mln di chf
21.01.BB BIOTECH : chiude 2021 con perdita di 405 mln chf
21.01.Principales informations avant-Bourse
21.01.BB Biotech boucle l'année 2021 sur une perte
21.01.BB Biotech Forecasts Switch to FY21 Loss in 'Difficult Year'
21.01.BB Biotech AG registra una perdita al termine dell'esercizio 2021
21.01.BB Biotech AG closes the 2021 fiscal year with a loss
21.01.BB BIOTECH AG : 2021 was a difficult year for biotech equity markets - increased dividend ..
21.01.BB BIOTECH AG : Un difficile 2021 per i titoli biotecnologici - Proposto un aumento del di..
21.01.BB Biotech AG Proposes a Regular Dividend
2021BORSA : Milano -1,22%, WS in calo
2021BB BIOTECH : «Cancer medicine improves the chances of a cure»
2021BB Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
1  2  3  4  5  6  7Weiter